ARCHIVES

New Technology May Enable Therapy Tailored To Patient’s Predicted Response

This article is from The Cancer Letter archive.

Vol. 25 No. 4 | April 26, 2002

Download PDF Visit The Full Archive

Related Articles

Letter In Response To Hadley; RFA Available

July 7, 1995

Chemoprevention Concept Approved By DCPC Bard Uses Biological Markers To Assess Risk Modulation

September 27, 1985

Cancer Telethon Attracts Small Audience, Generates Expectations-And Questions.

September 12, 2008

The Selling Begins: CT Offered Beyond High-Risk Group

November 26, 2010

Ilex Oncology Buys Symphar, Controls Drug For Bone Mets.

March 2, 2001

NCI Criticized For Delays In Development Of New Drugs

January 24, 1975